Logo image of NBY

NOVABAY PHARMACEUTICALS INC (NBY) Stock Analyst Ratings

NYSEARCA:NBY - NYSE Arca - US66987P4090 - Common Stock - Currency: USD

0.58  -0.03 (-4.26%)

After market: 0.595 +0.02 (+2.59%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to NBY. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 0.87. This target is 49.48% above the current price.
NBY was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NBY.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed NBY. So this is just the average opinion of a couple of analysts.
NBY Historical Analyst RatingsNBY Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -102 -92 -82 -72 -62 -52 -42 -32 -22 -12 -2 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 0.580.860.870.870.89 - 48.02% 49.48% 49.48% 53.88%
NBY Current Analyst RatingNBY Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2024-11-11 Ascendiant Capital Maintains Buy -> Buy
2023-08-11 Ladenburg Thalmann Maintains Buy -> Buy
2022-05-20 Ascendiant Capital Maintains Buy